阿里健康、阿里巴巴涨近5%，小鹏汽车涨超4%，比亚迪股份涨超3%。 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何 意见、观点或结论是否符合其特定状况。据此投资，责任自负。 风险提示及免责条款 ...

▲南宁市以互联网及信息技术为依托，建设"南宁云医院"平台。 ■本报记者廖欣 罗屹钦 "李奶奶，早上好！我来为您做检查了。"近日，在青秀区中山路东二里一居民家中，95岁的李奶奶躺在床上，护士刘丽霞轻声问候，随后俯身给李奶奶量血 压、消毒、静脉采血，动作娴熟而轻柔。这温情一幕，正是南宁市大力打造"南宁云医院"平台，破解群众就医难题的生动缩影。 随着老龄化进程加快，术后康复、老年照护、慢病管理等需求日益增长。对于行动不便的老人、失能人群和母婴人群来说，出门就医成为一大难题。作为广 西首个"互联网+护理"服务试点城市，自2022年以来，南宁市以互联网及信息技术为依托，建设"南宁云医院"平台，构建涵盖医、护、药的"互联网+健康医 ▶在南宁市中医医院新华院区，妇科副主任医师明珠通过"南宁云医院"平台为市民提供线上问诊服务。 本报记者廖欣 摄 小平台托举大民生。记者从南宁市卫生健康委员会了解到，目前全市有84家医疗机构超3300名医生、超6700名护士入驻"南宁云医院"平台，提供超过180项 线上线下服务。平台按"就近匹配+双模式派单"调度，确保15分钟服务半径覆盖。 "能上门服务的护士，都是经过严格筛选的。"刘丽霞介绍， ...

Core Insights - Ping An Good Doctor and Yimai Qingteng signed a cooperation agreement to enhance AI technology in medical services, focusing on intelligent recommendations and diagnostic assistance [1][4] - The partnership aims to create a seamless healthcare service loop, ensuring accessibility, reliability, and continuity in health management [1][3] Group 1: Company Collaboration - The collaboration will leverage Yimai Qingteng's expertise in medical imaging to enhance Ping An Good Doctor's service system, which includes "to line, to hospital, to home, and to enterprise" [3][5] - Both companies will explore AI-assisted medical applications, aiming for deep integration across the entire healthcare process from diagnosis to management [4][5] Group 2: Industry Context - The partnership aligns with the "Healthy China 2030" national strategy, addressing the evolving health needs of the population for integrated, human-centered solutions [5] - The collaboration is seen as a significant step towards overcoming industry challenges such as uneven resource distribution and fragmented service chains, enhancing user experience in healthcare [5]

Core Viewpoint - The newly launched Hong Kong Stock Connect Medical ETF by Huabao (159137) is expected to perform actively due to the rising interest in the medical sector and favorable market conditions, coinciding with a strong performance in both the Hong Kong and A-share medical sectors at the beginning of 2026 [1][2]. Group 1: ETF Launch and Market Context - The Hong Kong Stock Connect Medical ETF Huabao (159137) was established on December 31, 2025, and began trading on January 12, 2026 [2]. - The underlying index, the "CSI Hong Kong Stock Connect Medical Theme Index," has seen a 14.25% increase from January 1 to January 9, 2026, and a total annual increase of 48.20% in 2025, indicating a strong recovery in the Hong Kong medical sector [2][4]. - The ETF's launch coincides with a rare "sixteen consecutive days of gains" in the Shanghai Composite Index, reflecting heightened investor enthusiasm [1]. Group 2: Investment Strategy and Composition - The ETF covers four major sectors within the Hong Kong medical field: CXO, medical business and services, medical devices, and biopharmaceuticals, with over 80% of its weight concentrated in leading companies in CXO, internet healthcare, and high-end medical devices [2][4]. - The top ten constituents of the index include major players such as WuXi Biologics (15.28% weight), JD Health (11.84%), and Alibaba Health (5.42%), collectively accounting for 63.89% of the index [4]. Group 3: Market Potential and Valuation - The Hong Kong medical sector is characterized by significant growth potential, driven by an aging population and increasing healthcare demands, with the CXO market expected to grow at a CAGR of 26.56% from 2020 to 2025 [4]. - The index's valuation remains relatively low, with a TTM P/E ratio of 29.43, which is below historical averages, suggesting a favorable entry point for investors [5].

Core Viewpoint - The newly launched Hong Kong Stock Connect Medical ETF, Huabao (159137), is expected to perform actively due to the rising interest in the medical sector and favorable market conditions, coinciding with the recent recovery of the Hong Kong and A-share medical sectors at the beginning of 2026 [1][14]. Group 1: ETF Launch and Market Context - The Hong Kong Stock Connect Medical ETF Huabao (159137) was established on December 31, 2025, and began trading on January 12, 2026 [1][15]. - The Shanghai Composite Index has recently shown a rare "sixteen consecutive days of gains," surpassing the 4100-point mark, indicating high investor enthusiasm [1][14]. - The Hong Kong Stock Connect Medical Theme Index has increased by 14.25% from January 1 to January 9, 2026, and had an annual increase of 48.20% in 2025, reflecting a significant recovery in the medical sector [1][15]. Group 2: ETF Composition and Investment Focus - The ETF tracks the CSI Hong Kong Stock Connect Medical Theme Index, covering four major areas: CXO, medical business and services, medical devices, and biopharmaceuticals, with over 80% of its weight concentrated in leading companies in CXO, internet healthcare, and high-end medical devices [2][15]. - More than 85% of the ETF's components are "Hong Kong exclusive" stocks, including unique offerings like JD Health and Alibaba Health, which provide investors with significant opportunities in the Hong Kong medical sector [2][15]. Group 3: Market Potential and Valuation - The Hong Kong medical sector is characterized as a "golden track" with substantial market potential, driven by an aging population and increasing healthcare demand, supported by a growing GDP per capita [4][19]. - The CSI Hong Kong Stock Connect Medical Theme Index is currently at a historical low, with a drop of over 65% from its peak in 2021, and a price-to-earnings ratio (TTM) of 29.43, which is below 65% of its historical range [6][19]. - The index's configuration offers a compelling cost-performance ratio, making the ETF a noteworthy investment tool for investors [6][19].

香港聯合交易所有限公司與證券及期貨事務監察委員會對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 本公司招股章程根據香港法例第32章公司（清盤及雜項條文）條例送呈香港公 司註冊處處長登記前，不會向香港公眾人士提出要約或邀請。倘於適當時候向 香港公眾人士提出要約或邀請，有意投資者務請僅依據與香港公司註冊處處 長登記的本公司招股章程作出投資決定，招股章程副本將於發售期內向公眾 人士提供。 We Doctor Holdings Limited 微醫控股有限公司 （於英屬維爾京群島註冊成立的有限公司並以存續方式於開曼群島註冊） 警告 本公告乃根據香港聯合交易所有限公司（「聯交所」）與證券及期貨事務監察委 員會（「證監會」）的要求而刊發，僅用作向香港公眾人士提供資料。 閣下閱覽本公告，即表示 閣下知悉、接納並向微醫控股有限公司（「本公司」）、 其保薦人、整體協調人、顧問或包銷團成員表示同意： – 2 – (e) 本公告（及其所載資料）僅供參考，並不構成或組成在美國（包括其領土及 屬地、美國任何州及哥倫比亞特區） ...

中新社香港1月9日电 (记者 戴小橦)港股三大指数9日齐涨，截至收盘，香港恒生指数涨0.32%，报 26231.79点；恒生科技指数涨0.15%，报5687.14点；国企指数涨0.1%，报9048.53点。 对于港股9日的反弹及后续走势，市场人士给出积极解读。盈立证券研究部执行董事黄德几表示，中国 内地经济数据向好，最新居民消费价格指数(CPI)同比增长0.8%，符合预期；工业生产者出厂价格指数 (PPI)也有所改善，这是推动港股9日出现轻微反弹的重要原因。(完) 1月9日，香港恒生指数收市报26231.79点，上升82.48点，升幅为0.32%，全日成交金额为2451.30亿港 元。 中新社记者 陈永诺 摄 回顾全周，港股市场呈现"开门红后震荡回调"的节奏。香港恒生指数在1月6日一度升至26858.13点，创 下自去年11月14日以来的最佳点位。同期恒生科技指数走势相近，单日最高触及5875.32点，同样刷新 2025年11月14日以来的新高。 板块方面，互联网医疗股走势亮眼，阿里健康领涨4.72%，平安好医生、京东健康涨幅超2.9%。黄金股 集体上扬，山东黄金涨6.12%，招金矿业、灵宝黄金等跟涨。有色金 ...

智通财经APP获悉，香港联交所最新资料显示，1月6日，摩根大通减持阿里健康(00241)2346.7799万 股，每股作价5.5024港元，总金额约为1.29亿港元。减持后最新持股数目约12.91亿股，最新持股比例为 7.97%。 ...

1月7日，京东健康医疗器械开新盛典在北京举行。会上，京东健康互联网医疗业务负责人出席并发表主 题演讲，系统分享了在互联网医疗高速发展的背景下，京东互联网医院如何通过构建全场景、全流程的 医疗服务能力，为医疗器械品牌增长与用户健康管理提供深度助力。 服务创新与闭环构建 引领医疗健康一体化新体验 当前，互联网医疗正迎来广泛普及与高速发展阶段。据行业预测，2025年我国互联网医疗市场规模将达 4799亿元，用户规模已突破4亿。京东互联网医院作为国内首批取得牌照的独立设置型互联网医院之 一，持续巩固"在线诊疗第一入口"地位，日均问诊咨询量超过50万，客户满意度达98.9%。 在持续提升综合服务能力的同时，京东互联网医院也重点加强了专科专病服务体系的建设。目前已陆续 升级皮肤医院、精神心理中心及中医院，并于2025年新增男科与肿瘤专科，与全国知名专家共建专病工 作室，持续夯实其在重点专科领域的服务深度与专业厚度。 如今，京东健康已建成覆盖"医、检、诊、药"的一站式闭环服务。从线上问诊、检验单开具、护士上门 检测，到报告解读、药品配送，用户足不出户即可完成全流程诊疗。此外，还支持全国多城市的影像检 查预约，进一步拓展了服 ...

新浪科技讯 1月9日上午消息，近日，京东健康互联网医疗业务负责人透露，京东互联网医院作为国内 首批取得牌照的独立设置型互联网医院之一，日均问诊咨询量超过50万，客户满意度达98.9%。 在持续提升综合服务能力的同时，京东互联网医院也重点加强了专科专病服务体系的建设。目前已陆续 升级皮肤医院、精神心理中心及中医院，并于2025年新增男科与肿瘤专科，与全国知名专家共建专病工 作室。 如今，京东健康已建成覆盖"医、检、诊、药"的一站式闭环服务。从线上问诊、检验单开具、护士上门 检测，到报告解读、药品配送，用户足不出户即可完成全流程诊疗。此外，还支持全国多城市的影像检 查预约，进一步拓展了服务边界。 该负责人提到，2025年，药械+医疗服务的闭环链接进一步拓展。此外，在助力医疗器械品牌成长方 面，京东互联网医院已形成从医生沟通、用户管理到医院场景触达等全链路支持体系。 新浪科技讯 1月9日上午消息，近日，京东健康互联网医疗业务负责人透露，京东互联网医院作为国内 首批取得牌照的独立设置型互联网医院之一，日均问诊咨询量超过50万，客户满意度达98.9%。 在持续提升综合服务能力的同时，京东互联网医院也重点加强了专科专病服 ...